VP-16 AND CARBOPLATIN IN PREVIOUSLY UNTREATED PATIENTS WITH EXTENSIVE SMALL CELL LUNG-CANCER - A STUDY OF THE NATIONAL CANCER INSTITUTE OF CANADA CLINICAL-TRIALS GROUP

被引:36
作者
EVANS, WK
EISENHAUER, E
HUGHES, P
MAROUN, JA
AYOUB, J
SHEPHERD, FA
FELD, R
机构
[1] KINGSTON REG CANC CTR,TORONTO,ONTARIO,CANADA
[2] TORONTO GEN HOSP,TORONTO M5G 1L7,ONTARIO,CANADA
[3] PRINCESS MARGARET HOSP,TORONTO M4X 1K9,ONTARIO,CANADA
关键词
D O I
10.1038/bjc.1988.242
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:464 / 468
页数:5
相关论文
共 17 条
[1]   CARBOPLATIN (CBDCA, JM-8) AND VP-16-213 IN PREVIOUSLY UNTREATED PATIENTS WITH SMALL-CELL LUNG-CANCER [J].
BISHOP, JF ;
RAGHAVAN, D ;
STUARTHARRIS, R ;
MORSTYN, G ;
ARONEY, R ;
KEFFORD, R ;
YUEN, K ;
LEE, J ;
GIANOUTSOS, P ;
OLVER, IN ;
ZALCBERG, J ;
BALL, D ;
BULL, C ;
FOX, R .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (10) :1574-1578
[2]   EARLY CLINICAL-STUDIES WITH CIS-DIAMMINE-1,1-CYCLOBUTANE DICARBOXYLATE PLATINUM-II [J].
CALVERT, AH ;
HARLAND, SJ ;
NEWELL, DR ;
SIDDIK, ZH ;
JONES, AC ;
MCELWAIN, TJ ;
RAJU, S ;
WILTSHAW, E ;
SMITH, IE ;
BAKER, JM ;
PECKHAM, MJ ;
HARRAP, KR .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 9 (03) :140-147
[3]   CARBOPLATIN - THE CLINICAL SPECTRUM TO DATE [J].
CANETTA, R ;
ROZENCWEIG, M ;
CARTER, SK .
CANCER TREATMENT REVIEWS, 1985, 12 :125-136
[4]  
EGORIN MJ, 1984, CANCER RES, V44, P5432
[5]  
EVANS WK, 1986, SEMIN ONCOL, V13, P17
[6]   VP-16 AND CISPLATIN AS 1ST-LINE THERAPY FOR SMALL-CELL LUNG-CANCER [J].
EVANS, WK ;
SHEPHERD, FA ;
FELD, R ;
OSOBA, D ;
DANG, P ;
DEBOER, G .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (11) :1471-1477
[7]   ETOPOSIDE (VP-16) AND CISPLATIN - AN EFFECTIVE TREATMENT FOR RELAPSE IN SMALL-CELL LUNG-CANCER [J].
EVANS, WK ;
OSOBA, D ;
FELD, R ;
SHEPHERD, FA ;
BAZOS, MJ ;
DEBOER, G .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (01) :65-71
[8]   SUPERIORITY OF ALTERNATING NON-CROSS-RESISTANT CHEMOTHERAPY IN EXTENSIVE SMALL-CELL LUNG-CANCER - A MULTICENTER, RANDOMIZED CLINICAL-TRIAL BY THE NATIONAL-CANCER-INSTITUTE-OF-CANADA [J].
EVANS, WK ;
FELD, R ;
MURRAY, N ;
WILLAN, A ;
COY, P ;
OSOBA, D ;
SHEPHERD, FA ;
CLARK, DA ;
LEVITT, M ;
MACDONALD, A ;
WILSON, K ;
SHELLEY, W ;
PATER, J .
ANNALS OF INTERNAL MEDICINE, 1987, 107 (04) :451-458
[9]  
GRECO FA, 1978, SEMIN ONCOL, V5, P323
[10]  
PORTER LL, 1985, CANCER TREAT REP, V69, P479